Director
Brent P. Forester, MD, MSc, is the chief of the Division of Geriatric Psychiatry at McLean Hospital, Senior Medical Director for Value-Based Care Solutions, Population Health Management at Mass General Brigham and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Forester is an expert in geriatric psychiatry, specializing in the treatment of older adults with depression, bipolar disorder, and behavioral complications of Alzheimer’s disease and related dementias. He is currently President of the American Association for Geriatric Psychiatry and a distinguished fellow of the American Psychiatric Association.
Dr. Forester graduated from Dartmouth Medical School in 1992 as a member of Alpha Omega Alpha Honor Society. He completed an internship in Internal Medicine at the Massachusetts General Hospital and a Residency in Psychiatry at McLean Hospital. Following this, he completed a fellowship in geriatric psychiatry at Dartmouth Hitchcock Medical Center. He returned to McLean Hospital in 2002 as the Medical Director of the Cognitive Neuropsychiatry Unit.
Dr. Forester’s research focuses on studying novel treatment interventions to manage behavioral complications of dementia such as agitation and aggression. Dr. Forester also leads two Mass General Brigham system-wide initiatives to enhance the assessment and treatment of individuals with dementia, while supporting family caregivers, in primary care settings. Finally, Dr. Forester and his research team use brain imaging techniques and careful clinical assessment to better understand the causes of dementia, depression and bipolar disorder in later life and to identify promising new targets for effective treatments.
Dr. Forester has published numerous articles and book chapters on topics including Geriatric Bipolar Disorder, the Behavioral and Psychological Symptoms of Dementia, and Late Life Depression. He also served a co-editor of the textbook, Bipolar Disorder in Older Age Patients, published by Springer in 2017.
Dr. Forester graduated from Dartmouth Medical School in 1992 as a member of Alpha Omega Alpha Honor Society. He completed an internship in Internal Medicine at the Massachusetts General Hospital and a Residency in Psychiatry at McLean Hospital. Following this, he completed a fellowship in geriatric psychiatry at Dartmouth Hitchcock Medical Center. He returned to McLean Hospital in 2002 as the Medical Director of the Cognitive Neuropsychiatry Unit.
Dr. Forester’s research focuses on studying novel treatment interventions to manage behavioral complications of dementia such as agitation and aggression. Dr. Forester also leads two Mass General Brigham system-wide initiatives to enhance the assessment and treatment of individuals with dementia, while supporting family caregivers, in primary care settings. Finally, Dr. Forester and his research team use brain imaging techniques and careful clinical assessment to better understand the causes of dementia, depression and bipolar disorder in later life and to identify promising new targets for effective treatments.
Dr. Forester has published numerous articles and book chapters on topics including Geriatric Bipolar Disorder, the Behavioral and Psychological Symptoms of Dementia, and Late Life Depression. He also served a co-editor of the textbook, Bipolar Disorder in Older Age Patients, published by Springer in 2017.
Associate Director
David G. Harper, Ph.D. is the Associate Director of Research in the Division of Geriatric Psychiatry. He serves as an Associate Psychologist at McLean Hospital and is an Assistant Professor of Psychology in the Department of Psychiatry at Harvard Medical School. Dr. Harper earned his Ph.D. in experimental psychology and neuroscience at Tufts University in 2000.
Dr. Harper’s chief research interests are in the development of disease modifying therapies to be used in the treatment of Alzheimer’s disease, understanding the behavioral and psychological symptoms seen in Alzheimer’s disease and other neurodegenerative dementias, and understanding cognitive disturbances in late life mood disorders. Dr. Harper uses a variety of tools in these studies, including resting state fMRI to quantify brain connectivity, analyzing cerebral blood flow in various psychiatric and neurological conditions and phosphorus spectroscopy to examine bioenergetics and cell membrane metabolism.
Dr. Harper has published widely in journals including Archives of General Psychiatry (now JAMA Psychiatry), Neurobiology of Aging, Brain, Neuropsychopharmacology and The American Journal of Geriatric Psychiatry. He has written numerous book chapters on subjects ranging from sleep and circadian rhythm disturbances in Alzheimer’s disease to phosphorus spectroscopy in psychiatric illness.
Dr. Harper’s chief research interests are in the development of disease modifying therapies to be used in the treatment of Alzheimer’s disease, understanding the behavioral and psychological symptoms seen in Alzheimer’s disease and other neurodegenerative dementias, and understanding cognitive disturbances in late life mood disorders. Dr. Harper uses a variety of tools in these studies, including resting state fMRI to quantify brain connectivity, analyzing cerebral blood flow in various psychiatric and neurological conditions and phosphorus spectroscopy to examine bioenergetics and cell membrane metabolism.
Dr. Harper has published widely in journals including Archives of General Psychiatry (now JAMA Psychiatry), Neurobiology of Aging, Brain, Neuropsychopharmacology and The American Journal of Geriatric Psychiatry. He has written numerous book chapters on subjects ranging from sleep and circadian rhythm disturbances in Alzheimer’s disease to phosphorus spectroscopy in psychiatric illness.
Co-Investigators |
|
|
Clinicians |
|
|
|
|
Dr. Jessenia Arias, Psy.D., is a clinical neuropsychologist who specializes in the assessment of adult and geriatric populations with a wide range of symptoms and diagnoses, such as neurodegenerative disease, mood/personality/psychotic disorders, and other disorders related to cognitive dysfunction. She completed her post-doctoral training at McLean Hospital and remained within the neuropsychology department as a staff neuropsychologist. She also performs clinical assessments for ongoing research projects and is assisting in numerous efforts to improve diversity, equity, and inclusion (DEI) efforts within McLean’s Geriatric Psychiatry Research Program.
Dr. Arias is also a recipient of the American Psychological Association’s Implementation Grants Fund (IGF) for Ethnic Minority Recruitment, Retention, and Training in Psychology, which awarded grant support for her novel project aimed to improve multicultural competence within the field of neuropsychology by creating a virtual platform for the collection and organization of neuropsychological normative data for Spanish-speaking populations, which aims to have significant research and clinical implications for multicultural populations. |
Post-Doctoral Fellows
Dr. Soohyun Park is currently a post-doctoral research fellow at McLean Hospital/Harvard Medical School in the Geriatric Psychiatry Research Program. Dr. Park is the 2022-2023 recipient of the Pope-Hintz fellowship at McLean hospital, which awards $50,000 grant support for her novel research project entitled “Interplay of Polygenic Risk Score, Adverse Childhood Experiences, and Psychological Resilience Factors on Late-life Depression among African American Older Adults.”
Dr. Park received her Ph.D. in Clinical Psychology, specializing in Geropsychology with a Statistics minor, from the University of Alabama in 2021. She completed the APA-accredited predoctoral clinical psychology internship at the University of Texas Health Science Center at San Antonio, with an emphasis on cognitive behavior therapy (CBT) in 2020-2021.
Dr. Park's program of research has focused on (a) integrative roles of genetic, environmental, and psychosocial protective/risk factors in late-life mental/cognitive health, and (b) mental health disparities in underserved racial/ethnic groups of older adults. As a scientist-practitioner, Dr. Park aims to apply a biopsychosocial approach to find out “modifiable” psychological factors as a target to promote the late-life mental and cognitive health of racially and ethnically diverse older adults.
Dr. Park received her Ph.D. in Clinical Psychology, specializing in Geropsychology with a Statistics minor, from the University of Alabama in 2021. She completed the APA-accredited predoctoral clinical psychology internship at the University of Texas Health Science Center at San Antonio, with an emphasis on cognitive behavior therapy (CBT) in 2020-2021.
Dr. Park's program of research has focused on (a) integrative roles of genetic, environmental, and psychosocial protective/risk factors in late-life mental/cognitive health, and (b) mental health disparities in underserved racial/ethnic groups of older adults. As a scientist-practitioner, Dr. Park aims to apply a biopsychosocial approach to find out “modifiable” psychological factors as a target to promote the late-life mental and cognitive health of racially and ethnically diverse older adults.
Current Research Staff
|
|
|
|
|
Keegan Lant, BS clinical research assistant II |
|
|
|
|
|
|
CLICK HERE TO VOLUNTEER FOR RESEARCH
McLean Hospital • South Belknap • 115 Mill Street, Belmont, MA 02478